Twin Peaks Wealth Advisors’s GSK GSK Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99K	Buy	+1,793	New	+$97.2K	0.02%	295
2025 Q3	–	Sell	-665	Closed	-$25.4K	–	976
2025 Q2	$25.4K	Buy	+665	New	+$25.4K	0.01%	521

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Twin Peaks Wealth Advisors's GSK Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in GSK (GSK) in Q1 2026: 1,793 shares worth $99K. The stake represents 0.02% of the portfolio and ranks #295 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in GSK as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in GSK in Q2 2025 and has held it in 2 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Twin Peaks Wealth Advisors held 1,793 shares of GSK worth $99K as of Q1 2026.
GSK was a new Twin Peaks Wealth Advisors position in Q1 2026.
GSK made up 0.02% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #295 holding.
Twin Peaks Wealth Advisors first reported a position in GSK in Q2 2025 and has held it in 2 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.